Ticagrelor Market Analysis: Key Drivers and Growth Factors
The Ticagrelor Market Analysis examines the factors contributing to the growth of the ticagrelor market. Ticagrelor, an antiplatelet medication, is primarily used to prevent blood clots in patients with acute coronary syndrome (ACS) or a history of heart attack. The market is driven by the increasing prevalence of cardiovascular diseases, the aging population, and the growing awareness of heart health. Additionally, advancements in pharmaceutical research and the rising incidence of ACS are contributing to market growth. The market is expected to expand from USD 1.79 billion in 2024 to USD 2.57 billion by 2029, at a compound annual growth rate (CAGR) of 7.4% .
2 vues